Recent advances in 17beta-hydroxysteroid dehydrogenases

Journal of Steroid Biochemistry and Molecular Biology

Volumn 114, Issue 1-2, 2009, Pages 72-77

  Prehn, Cornelia ^a   Möller, Gabriele ^a   Adamski, Jerzy ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Phylogenetics; Short chain dehydrogenase reductase; Steroid metabolism; Steroid related diseases

Indexed keywords

TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE 1; TESTOSTERONE 17BETA DEHYDROGENASE 10; TESTOSTERONE 17BETA DEHYDROGENASE 11; TESTOSTERONE 17BETA DEHYDROGENASE 12; TESTOSTERONE 17BETA DEHYDROGENASE 13; TESTOSTERONE 17BETA DEHYDROGENASE 14; TESTOSTERONE 17BETA DEHYDROGENASE 2; TESTOSTERONE 17BETA DEHYDROGENASE 3; TESTOSTERONE 17BETA DEHYDROGENASE 4; TESTOSTERONE 17BETA DEHYDROGENASE 5; TESTOSTERONE 17BETA DEHYDROGENASE 6; TESTOSTERONE 17BETA DEHYDROGENASE 7; TESTOSTERONE 17BETA DEHYDROGENASE 8; TESTOSTERONE 17BETA DEHYDROGENASE 9; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; LIPID METABOLISM; METABOLOMICS; NONHUMAN; SIGNAL TRANSDUCTION; STEROID METABOLISM;

17-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; DRUG DESIGN; HUMANS; ISOENZYMES; LIPID METABOLISM; METABOLOMICS; MOLECULAR STRUCTURE; STEROIDS;

EID: 63149166711     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.12.024     Document Type: Article

References (109)

1. Abalain J.H., Di S.S., Amet Y., Quemener E., Abalain C.M., and Floch H.H. Cloning, DNA sequencing and expression of (3-17)beta hydroxysteroid dehydrogenase from Pseudomonas testosteroni. J. Steroid Biochem. Mol. Biol. 44 2 (1993) 133-139
2. Mobus E., and Maser E. Molecular cloning, overexpression, and characterization of steroid- inducible 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni. A novel member of the short-chain dehydrogenase/reductase superfamily. J. Biol. Chem. 273 47 (1998) 30888-30896
3. Lanisnik T., Zakelj-Mavric M., and Belic I. Fungal 17 beta-hydroxysteroid dehydrogenase. FEMS Microbiol. Lett. 78 1 (1992) 49-52
4. Itagaki E., and Iwaya T. Purification and characterization of 17 beta-hydroxysteroid dehydrogenase from Cylindrocarpon radicicola. J. Biochem. (Tokyo) 103 6 (1988) 1039-1044
5. Tarrant A.M., Blomquist C.H., Lima P.H., Atkinson M.J., and Atkinson S. Metabolism of estrogens and androgens by scleractinian corals. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 136 3 (2003) 473-485
6. Patel D.S., Fang L.L., Svy D.K., Ruvkun G., and Li W. Genetic identification of HSD-1, a conserved steroidogenic enzyme that directs larval development in Caenorhabditis elegans. Development 135 13 (2008) 2239-2249
7. Kurzchalia T.V., and Ward S. Why do worms need cholesterol?. Nat. Cell. Biol. 5 8 (2003) 684-688
8. Mindnich R., and Adamski J. Functional genome analysis indicates loss of 17beta-hydroxysteroid dehydrogenase type 2 enzyme in the zebrafish. J. Steroid Biochem. Mol. Biol. 103 1 (2007) 35-43
9. Kazeto Y., Ijiri S., Matsubara H., Adachi S., and Yamauchi K. Cloning of 17beta-hydroxysteroid dehydrogenase-I cDNAs from Japanese eel ovary. Biochem. Biophys. Res. Commun. 279 2 (2000) 451-456
10. Smith C.A., and Joss J.M. Steroidogenic enzyme activity and ovarian differentiation in the saltwater crocodile, Crocodylus porosus. Gen. Comp. Endocrinol. 93 2 (1994) 232-245
11. Mensah-Nyagan A.M., Feuilloley M., Do-Rego J.L., Marcual A., Lange C., Tonon M.C., Pelletier G., and Vaudry H. Localization of 17beta-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc. Natl. Acad. Sci. U.S.A. 93 4 (1996) 1423-1428
12. Bhujle B.V., and Nadkarni V.B. Hydroxysteroid dehydrogenases in the kidney of white-breasted water hen, Amaurornis phoenicurus chinensis (Boddaert). Acta Histochem. 54 2 (1975) 284-289
13. Wajima Y., Furusawa T., Kawauchi S., Wakabayashi N., Nakabayashi O., Nishimori K., and Mizuno S. The cDNA cloning and transient expression of an ovary-specific 17beta-hydroxysteroid dehydrogenase of chickens. Gene 233 1-2 (1999) 75-82
14. Moeller G., and Adamski J. Multifunctionality of human 17β-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 248 1-2 (2006) 47-55
15. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
16. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., and Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 70 (2008) 165-190
17. Zeillinger R., Kury F., Czerwenka K., Kubista E., Sliutz G., Knogler W., Huber J., Zielinski C., Reiner G., Jakesz R., et al. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene 4 1 (1989) 109-114
18. Shou J., Massarweh S., Osborne C.K., Wakeling A.E., Ali S., Weiss H., and Schiff R. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J. Natl. Cancer Inst. 96 12 (2004) 926-935
19. Jensen E.V. The contribution of "alternative approaches" to understanding steroid hormone action. Mol. Endocrinol. 19 6 (2005) 1439-1442
20. Wu R.C., Smith C.L., and O'Malley B.W. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr. Rev. 26 3 (2005) 393-399
21. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., and Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87 3 (2007) 905-931
22. Möller G., and Adamski J. Integrated view on 17beta-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 301 1-2 (2009) 7-19
23. Lukacik P., Kavanagh K.L., and Oppermann U. Structure and function of human 17beta-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 248 1-2 (2006) 61-71
24. J.E. Donald, E.I. Shakhnovich, SDR: a database of predicted specificity-determining residues in proteins, Nucleic Acids Res., in press.
25. B. Persson, J. Adamski, J. Bray, B. Bruford, S.L. Dellaporta, R. Gonzalez Duarte, H. Jörnvall, Y. Kallberg, K.L. Kavanagh, N. Kedishvili, M. E., S. Orchard, T.M. Penning, J. Thornton, U. Oppermann, The short-chain dehydrogenase/reductase (SDR) nomenclature initiative, Chemico-Biol. Interact., in press.
26. Dufort I., Rheault P., Huang X.F., Soucy P., and Luu-The V. Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology 140 2 (1999) 568-574
27. Jin Y., Penning T.M., and Aldo-keto reductases and bioactivation/detoxication. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 263-292
28. Hopkins A.L., and Groom C.R. The druggable genome. Nat. Rev. 1 9 (2002) 727-730
29. Biswas M.G., and Russell D.W. Expression cloning and characterization of oxidative 17beta- and 3alpha-hydroxysteroid dehydrogenases from rat and human prostate. J. Biol. Chem. 272 25 (1997) 15959-15966
30. Su J., Lin M., and Napoli J.L. Complementary deoxyribonucleic acid cloning and enzymatic characterization of a novel 17beta/3alpha-hydroxysteroid/retinoid short chain dehydrogenase/reductase. Endocrinology 140 11 (1999) 5275-5284
31. Oppermann U.C., Maser E., Hermans J.J., Koolman J., and Netter K.J. Homologies between enzymes involved in steroid and xenobiotic carbonyl reduction in vertebrates, invertebrates and procaryonts. J. Steroid Biochem. Mol. Biol. 43 7 (1992) 665-675
32. Baker M. Evolution of 17β-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action. Mol. Cell. Endocrinol. 171 (2001) 211-215
33. Leenders F., Husen B., Thole H.H., and Adamski J. The sequence of porcine 80 kDa 17β-estradiol dehydrogenase reveals similarities to the short chain alcohol dehydrogenase family, to actin binding motifs and to sterol carrier protein 2. Mol. Cell. Endocrinol. 104 (1994) 127-131
34. Leenders F., Tesdorpf J.G., Markus M., Engel T., Seedorf U., and Adamski J. Porcine 80-kDa protein reveals intrinsic 17 beta-hydroxysteroid dehydrogenase, fatty acyl-CoA-hydratase/dehydrogenase, and sterol transfer activities. J. Biol. Chem. 271 10 (1996) 5438-5442
35. Normand T., Husen B., Leenders F., Pelczar H., Baert J.L., Begue A., Flourens A.C., Adamski J., and de Launoit Y. Molecular characterization of mouse 17 beta-hydroxysteroid dehydrogenase IV. J. Steroid Biochem. Mol. Biol. 55 5-6 (1995) 541-548
36. Adamski J., Normand T., Leenders F., Monte D., Begue A., Stehelin D., Jungblut P.W., and de Launoit Y. Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV. Biochem. J. 311 Pt 2 (1995) 437-443
37. van Grunsven E.G., van Berkel E., Mooijer P.A., Watkins P.A., Moser H.W., Suzuki Y., Jiang L.L., Hashimoto T., Hoefler G., Adamski J., and Wanders R.J. Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basis. Am. J. Hum. Genet. 64 1 (1999) 99-107
38. van Grunsven E.G., van Berkel E., Ijlst L., Vreken P., de Klerk J.B., Adamski J., Lemonde H., Clayton P.T., Cuebas D.A., and Wanders R.J. Peroxisomal d-hydroxyacyl-CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proc. Natl. Acad. Sci. U.S.A. 95 5 (1998) 2128-2133
39. Baes M., Huyghe S., Carmeliet P., Declercq P.E., Collen D., Mannaerts G.P., and Van Veldhoven P.P. Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids. J. Biol. Chem. 275 21 (2000) 16329-16336
40. Luu-The V., Tremblay P., and Labrie F. Characterization of type 12 17{beta}-hydroxysteroid dehydrogenase (17{beta}-HSD12), an isoform of type 3 17{beta}-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol. Endocrinol. 20 2 (2006) 437-443
41. Moon Y., and Horton J. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J. Biol. Chem. 278 (2003) 7335-7343
42. Entchev E.V., Schwudke D., Zagoriy V., Matyash V., Bogdanova A., Habermann B., Zhu L., Shevchenko A., and Kurzchalia T.V. LET-767 is required for the production of branched chain and long chain fatty acids in Caenorhabditis elegans. J. Biol. Chem. 283 25 (2008) 17550-17560
43. Jansson A.K., Gunnarsson C., Cohen M., Sivik T., and Stal O. 17Beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer. Cancer Res. 66 23 (2006) 11471-11477
44. Day J.M., Foster P.A., Tutill H.J., Parsons M.F., Newman S.P., Chander S.K., Allan G.M., Lawrence H.R., Vicker N., Potter B.V., Reed M.J., and Purohit A. 17Beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer. Int. J. Cancer 122 9 (2008) 1931-1940
45. Meier M., Möller G., and Adamski J. Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease. Ann. N. Y. Acad. Sci. 1155 (2009) 15-24
46. Marijanovic Z., Laubner D., Moller G., Gege C., Husen B., Adamski J., and Breitling R. Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Mol. Endocrinol. 17 9 (2003) 1715-1725
47. Guggenberger C., Ilgen D., and Adamski J. Functional analysis of cholesterol biosynthesis by RNA interference. J. Steroid Biochem. Mol. Biol. 104 3-5 (2007) 105-109
48. Rantakari P., Strauss L., Kiviranta R., Lagerbohm H., Paviala J., Holopainen I., Vainio S., Pakarinen P., and Poutanen M. Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene. Mol. Endocrinol. 22 3 (2008) 665-675
49. Lukacik P., Keller B., Bunkoczi G., Kavanagh K.L., Lee W.H., Adamski J., and Oppermann U. Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity. Biochem. J. 402 3 (2007) 419-427
50. Meier M., Tokarz J., Haller F., Mindnich R., and Adamski J. Human and zebrafish hydroxysteroid dehydrogenase like 1 (HSDL1) proteins are inactive enzymes but conserved among species. Chemico-Biol. Interact. 178 1-3 (2009) 197-205
51. Langer L.J., and Engel L.L. Human placental estradiol-17beta; dehydrogenase. I. concentration, characterization and assay. J. Biol. Chem. 233 (1958) 583-588
52. Penning T.M., Burczynski M.E., Jez J.M., Lin H.K., Ma H., Moore M., Ratnam K., and Palackal N. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3). Mol. Cell. Endocrinol. 171 1-2 (2001) 137-149
53. Wu L., Einstein M., Geissler W.M., Chan H.K., Elliston K.O., and Andersson S. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha- hydroxysteroid dehydrogenase activity. J. Biol. Chem. 268 17 (1993) 12964-12969
54. Geissler W., Davis D., Wu L., Bradshaw K., Patel S., Mendonca B., Elliston K., Wilson J., Russell D., and Andersson S. Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat. Genet. 7 (1994) 34-39
55. Koster H., Little D.P., Luan P., Muller R., Siddiqi S.M., Marappan S., and Yip P. Capture compound mass spectrometry: a technology for the investigation of small molecule protein interactions. Assay Drug Dev. Technol. 5 3 (2007) 381-390
56. Gileadi O., Knapp S., Lee W.H., Marsden B.D., Muller S., Niesen F.H., Kavanagh K.L., Ball L.J., von Delft F., Doyle D.A., Oppermann U.C., and Sundstrom M. The scientific impact of the structural genomics consortium: a protein family and ligand-centered approach to medically-relevant human proteins. J. Struct. Funct. Genomics 8 2-3 (2007) 107-119
57. Ng S.S., Kavanagh K.L., McDonough M.A., Butler D., Pilka E.S., Lienard B.M., Bray J.E., Savitsky P., Gileadi O., von Delft F., Rose N.R., Offer J., Scheinost J.C., Borowski T., Sundstrom M., Schofield C.J., and Oppermann U. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448 7149 (2007) 87-91
58. Favia A.D., Nobeli I., Glaser F., and Thornton J.M. Molecular docking for substrate identification: the short-chain dehydrogenases/reductases. J. Mol. Biol. 375 3 (2008) 855-874
59. Di Costanzo L., Drury J.E., Penning T.M., and Christianson D.W. Crystal structure of human liver Delta4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysis. J. Biol. Chem. 283 24 (2008) 16830-16839
60. Lee H.W., Lukacik P., Guo K., Ugochukwu E., Kavanagh K.L., Marsden B., and Oppermann U. Structure-activity relationships of human AKR-type oxidoreductases involved in bile acid synthesis: AKR1D1 and AKR1C4. Mol. Cell. Endocrinol. 301 1-2 (2009) 199-204
61. Tuncbag N., Gursoy A., Guney E., Nussinov R., and Keskin O. Architectures and functional coverage of protein-protein interfaces. J. Mol. Biol. 381 3 (2008) 785-802
62. Brosic P., Risner T.L., and Gobec S. Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. Curr. Med. Chem. 15 2 (2008) 137-150
63. Vicker N., Sharland C.M., Heaton W.B., Gonzalez A.M., Bailey H.V., Smith A., Springall J.S., Day J.M., Tutill H.J., Reed M.J., Purohit A., and Potter B.V. The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors. Mol. Cell. Endocrinol. 301 1-2 (2009) 259-265
64. Berube M., and Poirier D. Chemical synthesis and in vitro biological evaluation of a phosphorylated bisubstrate inhibitor of type 3 17beta-hydroxysteroid dehydrogenase. J. Enzyme Inhib. Med. Chem. 22 2 (2007) 201-211
65. Deluca D., Moller G., Rosinus A., Elger W., Hillisch A., and Adamski J. Inhibitory effects of fluorine-substituted estrogens on the activity of 17beta-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 248 1-2 (2006) 218-224
66. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., Hewison M., and Stewart P.M. 11Beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 25 5 (2004) 831-866
67. Oppermann U. Type 1 11beta-hydroxysteroid dehydrogenase as universal drug target in metabolic diseases?. Endocr. Metab. Immune Disord. Drug Targets 6 3 (2006) 259-269
68. Schnackenberg C.G. 11Beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome. Curr. Opin. Investig. Drugs 9 3 (2008) 295-300
69. Blouin K., Boivin A., and Tchernof A. Androgens and body fat distribution. J. Steroid Biochem. Mol. Biol. 108 3-5 (2008) 272-280
70. Blouin K., Richard C., Brochu G., Hould F.S., Lebel S., Marceau S., Biron S., Luu-The V., and Tchernof A. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. J. Endocrinol. 191 3 (2006) 637-649
71. Wake D.J., Strand M., Rask E., Westerbacka J., Livingstone D.E., Soderberg S., Andrew R., Yki-Jarvinen H., Olsson T., and Walker B.R. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin. Endocrinol. (Oxf.) 66 3 (2007) 440-446
72. Misso M.L., Hewitt K.N., Boon W.C., Murata Y., Jones M.E., and Simpson E.R. Cholesterol feeding prevents adiposity in the obese female aromatase knockout (ArKO) mouse. Horm. Metab. Res. 37 1 (2005) 26-31
73. Misso M.L., Murata Y., Boon W.C., Jones M.E., Britt K.L., and Simpson E.R. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 144 4 (2003) 1474-1480
74. Foryst-Ludwig A., Clemenz M., Hohmann S., Hartge M., Sprang C., Frost N., Krikov M., Bhanot S., Barros R., Morani A., Gustafsson J.A., Unger T., and Kintscher U. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet. 4 6 (2008) e1000108
75. Altmaier E., Ramsay S.L., Graber A., Mewes H.W., Weinberger K.M., and Suhre K. Bioinformatics analysis of targeted metabolomics-uncovering old and new tales of diabetic mice under medication. Endocrinology 49 7 (2008) 3478-3489
76. Watkins S.M., Reifsnyder P.R., Pan H.J., German J.B., and Leiter E.H. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43 11 (2002) 1809-1817
77. Chen J., Zhao X., Fritsche J., Yin P., Schmitt-Kopplin P., Wang W., Lu X., Haring H.U., Schleicher E.D., Lehmann R., and Xu G. Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Anal. Chem. 80 4 (2008) 1280-1289
78. Griffiths W.J., Karu K., Hornshaw M., Woffendin G., and Wang Y. Metabolomics and metabolite profiling: past heroes and future developments. Eur. J. Mass Spectrom. (Chichester, Eng) 13 1 (2007) 45-50
79. Gieger C., Geistlinger L., Altmaier E., Hrabé de Angelis M., Kronenberg M., Meitinger T., Mewes H.W., Wichmann H.E., Weinberger K.M., Adamski J., Illig T., and Suhre K. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS ONE 3 12 (2008) e3863
80. Kinross J.M., von Roon A.C., Holmes E., Darzi A., and Nicholson J.K. The human gut microbiome: implications for future health care. Curr. Gastroenterol. Rep. 10 4 (2008) 396-403
81. Jia W., Li H., Zhao L., and Nicholson J.K. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. 7 2 (2008) 123-129
82. Poutanen M., Miettinen M., and Vihko R. Differential estrogen substrate specificities for transiently expressed human placental 17 beta-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells. Endocrinology 133 6 (1993) 2639-2644
83. Dumont M., Luu-The V., Dupont E., Pelletier G., and Labrie F. Characterization, expression, and immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. J. Invest. Dermatol. 99 4 (1992) 415-421
84. Suzuki T., Sasano H., Andersson S., and Mason J.I. 3Beta-hydroxysteroid dehydrogenase/delta5-->4-isomerase activity associated with the human 17beta-hydroxysteroid dehydrogenase type 2 isoform. J. Clin. Endocrinol. Metab. 85 10 (2000) 3669-3672
85. Adamski J., Husen B., Marks F., and Jungblut P.W. Purification and properties of oestradiol 17 beta-dehydrogenase extracted from cytoplasmic vesicles of porcine endometrial cells. Biochem. J. 288 Pt 2 (1992) 375-381
86. Suzuki Y., Jiang L.L., Souri M., Miyazawa S., Fukuda S., Zhang Z., Une M., Shimozawa N., Kondo N., Orii T., and Hashimoto T. d-3-Hydroxyacyl-CoA dehydratase/d-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: a newly identified peroxisomal disorder. Am. J. Hum. Genet. 61 5 (1997) 1153-1162
87. Van Veldhoven P.P., Croes K., Asselberghs S., Herdewijn P., and Mannaerts G.P. Peroxisomal beta-oxidation of 2-methyl-branched acyl-CoA esters: stereospecific recognition of the 2S-methyl compounds by trihydroxycoprostanoyl-CoA oxidase and pristanoyl-CoA oxidase. FEBS Lett. 388 1 (1996) 80-84
88. Dieuaide-Noubhani M., Asselberghs S., Mannaerts G.P., and Van Veldhoven P.P. Evidence that multifunctional protein 2, and not multifunctional protein 1, is involved in the peroxisomal beta-oxidation of pristanic acid. Biochem. J. 325 2 (1997) 367-373
89. Dieuaide M., Novikov D.K., Carchon H., Van Veldhoven P.P., and Mannaerts G.P. Substrate stereospecificities of rat liver peroxisomal 3-hydroxyacyl-CoA dehydrogenases. Ann. N.Y. Acad. Sci. 804 (1996) 680-681
90. Penning T.M., Burczynski M.E., Jez J.M., Hung C.F., Lin H.K., Ma H., Moore M., Palackal N., and Ratnam K. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 351 Pt 1 (2000) 67-77
91. Steckelbroeck S., Jin Y., Gopishetty S., Oyesanmi B., and Penning T.M. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J. Biol. Chem. 279 11 (2004) 10784-10795
92. Matsuura K., Shiraishi H., Hara A., Sato K., Deyashiki Y., Ninomiya M., and Sakai S. Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J. Biochem. (Tokyo) 124 5 (1998) 940-946
93. Huang X.F., and Luu-The V. Molecular characterization of a first human 3(alpha-->beta)-hydroxysteroid epimerase. J. Biol. Chem. 275 38 (2000) 29452-29457
94. Jones M.R., Italiano L., Wilson S.G., Mullin B.H., Mead R., Dudbridge F., Watts G.F., and Stuckey B.G. Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. Fertil. Steril. 86 5 (2006) 1438-1446
95. Torn S., Nokelainen P., Kurkela R., Pulkka A., Menjivar M., Ghosh S., Coca-Prados M., Peltoketo H., Isomaa V., and Vihko P. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem. Biophys. Res. Commun. 305 1 (2003) 37-45
96. Ohno S., Nishikawa K., Honda Y., and Nakajin S. Expression in E. coli and tissue distribution of the human homologue of the mouse Ke 6 gene, 17beta-hydroxysteroid dehydrogenase type 8. Mol. Cell. Biochem. 309 1-2 (2008) 209-215
97. Wang J., Chai X., Eriksson U., and Napoli J.L. Activity of human 11-cis-retinol dehydrogenase (Rdh5) with steroids and retinoids and expression of its mRNA in extra-ocular human tissue. Biochem. J. 338 Pt 1 (1999) 23-27
98. He X.Y., Schulz H., and Yang S.Y. A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease. J. Biol. Chem. 273 17 (1998) 10741-10746
99. He X.Y., Merz G., Mehta P., Schulz H., and Yang S.Y. Human brain short chain l-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase. J. Biol. Chem. 274 21 (1999) 15014-15019
100. Shafqat N., Marschall H.U., Filling C., Nordling E., Wu X.Q., Bjork L., Thyberg J., Martensson E., Salim S., Jornvall H., and Oppermann U. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD. Biochem. J. 376 Pt 1 (2003) 49-60
101. He X.Y., Wegiel J., Yang Y.Z., Pullarkat R., Schulz H., and Yang S.Y. Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors. Mol. Cell. Endocrinol. 229 1-2 (2005) 111-117
102. Ofman R., Ruiter J.P., Feenstra M., Duran M., Poll-The B.T., Zschocke J., Ensenauer R., Lehnert W., Sass J.O., Sperl W., and Wanders R.J. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene. Am. J. Hum. Genet. 72 5 (2003) 1300-1307
103. Li K.X., Smith R.E., and Krozowski Z.S. Cloning and expression of a novel tissue specific 17beta-hydroxysteroid dehydrogenase. Endocr. Res. 24 3-4 (1998) 663-667
104. Brereton P., Suzuki T., Sasano H., Li K., Duarte C., Obeyesekere V., Haeseleer F., Palczewski K., Smith I., Komesaroff P., and Krozowski Z. Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung. Mol. Cell. Endocrinol. 171 1-2 (2001) 111-117
105. Luu-The V., Tremblay P., and Labrie F. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol. Endocrinol. 20 2 (2006) 437-443
106. Blanchard P.G., and Luu-The V. Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17beta-hydroxysteroid dehydrogenase. J. Endocrinol. 194 2 (2007) 449-455
107. Liu S., Huang C., Li D., Ren W., Zhang H., Qi M., Li X., and Yu L. Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase/reductase 9. Acta Biochim. Pol. 54 1 (2007) 213-218
108. Deluca D., Fritz A., Mindnich R., Möller G., and Adamski J. Biochemical genetics of 17beta-hydroxysteroid dehydrogenases. Curr. Topics Steroid Res. 4 (2004) 227-242
109. Liu H., Robert A., and Luu-The V. Cloning and characterization of human form 2 type 7 17beta-hydroxysteroid dehydrogenase, a primarily 3beta-keto reductase and estrogen activating and androgen inactivating enzyme. J. Steroid Biochem. Mol. Biol. 94 1-3 (2005) 173-179